Healthcare provider profile · identity verified

Michael Ehrig, MD

Internal Medicine · BETHLEHEM, PA · NPI 1871544262

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	716	203
Atorvastatin Calcium	Atorvastatin Calcium	654	173
Losartan Potassium	Losartan Potassium	646	173
Levothyroxine Sodium	Levothyroxine Sodium	552	150
Rosuvastatin Calcium	Rosuvastatin Calcium	374	109
Pantoprazole Sodium	Pantoprazole Sodium	330	93
Lisinopril	Lisinopril	291	81
Lorazepam	Lorazepam	285	68
Omeprazole	Omeprazole	283	90
Metformin Hcl	Metformin Hcl	267	77
Metoprolol Succinate	Metoprolol Succinate	267	71
Gabapentin	Gabapentin	238	76
Tramadol Hcl	Tramadol Hcl	206	45
Simvastatin	Simvastatin	203	58
Alprazolam	Alprazolam	201	48
Eliquis	Apixaban	191	48
Jardiance	Empagliflozin	189	54
Metoprolol Tartrate	Metoprolol Tartrate	171	49
Trazodone Hcl	Trazodone Hcl	158	50
Glimepiride	Glimepiride	154	44
Fluticasone Propionate	Fluticasone Propionate	153	55
Montelukast Sodium	Montelukast Sodium	152	53
Atenolol	Atenolol	142	37
Sertraline Hcl	Sertraline Hcl	136	39
Zolpidem Tartrate	Zolpidem Tartrate	135	35
Synthroid	Levothyroxine Sodium	120	33
Escitalopram Oxalate	Escitalopram Oxalate	118	24
Tamsulosin Hcl	Tamsulosin Hcl	117	38
Furosemide	Furosemide	116	41
Torsemide	Torsemide	113	37
Hydrochlorothiazide	Hydrochlorothiazide	112	35
Mirtazapine	Mirtazapine	112	32
Clopidogrel	Clopidogrel Bisulfate	108	32
Duloxetine Hcl	Duloxetine Hcl	107	31
Allopurinol	Allopurinol	104	27
Albuterol Sulfate Hfa	Albuterol Sulfate	103	35
Famotidine	Famotidine	103	28
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	103	31
Metformin Hcl Er	Metformin Hcl	98	28
Prednisone	Prednisone	93	54
Chlorthalidone	Chlorthalidone	92	23
Citalopram Hbr	Citalopram Hydrobromide	85	22
Clonazepam	Clonazepam	85	19
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	80	15
Ezetimibe	Ezetimibe	77	22
Carvedilol	Carvedilol	68	20
Doxycycline Hyclate	Doxycycline Hyclate	67	50
Triamcinolone Acetonide	Triamcinolone Acetonide	66	35
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	65	18
Oxycodone Hcl	Oxycodone Hcl	64	12
Pravastatin Sodium	Pravastatin Sodium	63	20
Tizanidine Hcl	Tizanidine Hcl	63	16
Doxazosin Mesylate	Doxazosin Mesylate	62	14
Ropinirole Hcl	Ropinirole Hcl	61	11
Paroxetine Hcl	Paroxetine Hcl	59	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	58	14
Meloxicam	Meloxicam	58	19
Finasteride	Finasteride	56	13
Pioglitazone Hcl	Pioglitazone Hcl	55	14
Temazepam	Temazepam	55	16
Xarelto	Rivaroxaban	55	11
Amitriptyline Hcl	Amitriptyline Hcl	54	14
Azithromycin	Azithromycin	53	41
Spironolactone	Spironolactone	52	17
Hydroxyzine Hcl	Hydroxyzine Hcl	51	15
Methylprednisolone	Methylprednisolone	49	42
Mounjaro	Tirzepatide	49	suppressed
Valsartan	Valsartan	49	16
Propranolol Hcl	Propranolol Hcl	47	11
Fluoxetine Hcl	Fluoxetine Hcl	45	16
Cephalexin	Cephalexin	44	26
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	44	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	44	13
Celecoxib	Celecoxib	43	15
Buspirone Hcl	Buspirone Hcl	42	17
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	42	15
Ozempic	Semaglutide	42	11
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	41	23
Diazepam	Diazepam	40	12
Bupropion Xl	Bupropion Hcl	39	12
Potassium Chloride	Potassium Chloride	39	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	38	15
Methocarbamol	Methocarbamol	37	15
Januvia	Sitagliptin Phosphate	34	suppressed
Tradjenta	Linagliptin	32	suppressed
Trulicity	Dulaglutide	32	suppressed
Fluconazole	Fluconazole	31	15
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	31	suppressed
Donepezil Hcl	Donepezil Hcl	30	13
Cholestyramine	Cholestyramine (With Sugar)	29	15
Dicyclomine Hcl	Dicyclomine Hcl	29	suppressed
Pregabalin	Pregabalin	29	suppressed
Amoxicillin	Amoxicillin	28	22
Ipratropium Bromide	Ipratropium Bromide	28	12
Ondansetron Hcl	Ondansetron Hcl	28	13
Paxlovid	Nirmatrelvir/Ritonavir	28	27
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	28	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	28	suppressed
Enalapril Maleate	Enalapril Maleate	27	suppressed
Meclizine Hcl	Meclizine Hcl	27	16
Propranolol Hcl Er	Propranolol Hcl	27	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	25	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	25	suppressed
Diclofenac Sodium	Diclofenac Sodium	24	15
Myrbetriq	Mirabegron	24	suppressed
Valacyclovir	Valacyclovir Hcl	24	suppressed
Mupirocin	Mupirocin	23	16
Levetiracetam	Levetiracetam	21	suppressed
Memantine Hcl	Memantine Hcl	20	suppressed
Midodrine Hcl	Midodrine Hcl	19	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	19	suppressed
Repaglinide	Repaglinide	19	suppressed
Solifenacin Succinate	Solifenacin Succinate	19	suppressed
Hydrocortisone	Hydrocortisone	18	12
Nitroglycerin	Nitroglycerin	18	suppressed
Sucralfate	Sucralfate	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	16
Nifedipine Er	Nifedipine	17	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	17	suppressed
Cefuroxime	Cefuroxime Axetil	16	14
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	suppressed
Potassium Citrate Er	Potassium Citrate	16	suppressed
Aspirin-Dipyridamole Er	Aspirin/Dipyridamole	15	suppressed
Calcitriol	Calcitriol	15	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	15	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Klor-Con M10	Potassium Chloride	14	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	14	suppressed
Primidone	Primidone	14	suppressed
Terazosin Hcl	Terazosin Hcl	14	suppressed
Benztropine Mesylate	Benztropine Mesylate	13	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Methimazole	Methimazole	13	suppressed
Naproxen	Naproxen	13	suppressed
Silodosin	Silodosin	13	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Colestipol Hcl	Colestipol Hcl	12	suppressed
Dutasteride-Tamsulosin	Dutasteride/Tamsulosin Hcl	12	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Nucynta	Tapentadol Hcl	12	suppressed
Ramipril	Ramipril	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Alendronate Sodium	Alendronate Sodium	11	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Humalog Mix 75-25	Insulin Lispro Protamin/Lispro	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed
Provigil	Modafinil	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Topiramate	Topiramate	11	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error